Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Ozge Soyer Kosemehmetoglu"'
Autor:
Ozge Soyer Kosemehmetoglu, Aynur Albayrak, Harika Okutan, Esra Saribacak Can, Vedat Aslan, Murat Albayrak, Birgül Öneç, Başak Ünver Koluman
Publikováno v:
Journal of Cancer Research and Therapeutics, Vol 14, Iss 5, Pp 1105-1111 (2018)
Aims: The prognosis of acute myeloid leukemia (AML) in elderly patients is worse due to age and comorbidities. Lately, monotherapy with hypomethylating agents like azacitidine (Aza) has been used to prolong overall survival (OS) in AML patients. Here
Autor:
Başak Ünver Koluman, Vedat Aslan, Ozge Soyer Kosemehmetoglu, Harika Okutan, Birgül Öneç, Murat Albayrak, Esra Saribacak Can
Publikováno v:
Indian Journal of Hematology and Blood Transfusion. 32:424-430
albayrak, murat/0000-0003-4025-741X WOS: 000386685400009 PubMed: 27812251 Multiple myeloma (MM) is a disease of the geriatric population with a median age at diagnosis of 69 years but most clinicians consider performance status and comorbidities rath
Autor:
Ozge Soyer Kosemehmetoglu, Başak Ünver Koluman, Vedat Aslan, Aynur Albayrak, Murat Albayrak, Birgül Öneç, Durdu Mehmet Kos, Harika Okutan, Esra Saribacak Can
Publikováno v:
Journal of Clinical Laboratory Analysis. 31:e22032
albayrak, murat/0000-0003-4025-741X; Onec, Birgul/0000-0003-2824-1044 WOS: 000397489300008 PubMed: 27500465 BackgroundRecent studies have shown a positive correlation between tumor-related immune response markers and the poor outcome in solid tumors.
Publikováno v:
Turkish Journal of Hematology, Vol 39, Iss 1, Pp 74-75 (2022)
Externí odkaz:
https://doaj.org/article/428b587e7c144bc5bfc7d343697ba70a